Curcumin phytosomal softgel formulation: Development, optimization and physicochemical characterization
References
- 1. R. K. Maheshwari, A. K. Singh, J. Gaddipati and R. C. Srimal, Multiple biological activities of curcumin: a short review,(2006) 2081–2087; DOI: 10.1016/j.lfs.2005.12.007.
- 2. R. Sharma, C. Ireson, R. Verschoyle, K. Hill, M. Williams, C. Leuratti, M. Manson, L. Marnett and W. Steward, Effects of dietary curcumin on glutathione-S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: relationship with drug levels,(2001) 1452–1458.
- 3. R. A. Sharma, S. A. Euden, S. L. Platton, D. N. Cooke, A. Shafayat, H. R. Hewitt, T. H. Marczylo, B. Morgan and D. Hemingway, Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance,(2004) 6847–6854.
- 4. A. Paradkar, A. A. Ambike, B. K. Jadhav and K. R. Mahadik, Characterization of curcumin-PVP solid dispersion obtained by spray drying,(2004) 281–286; DOI: 10.1016/j.ijpharm.2003.11.014.
- 5. M. H. Leung, H. Colangelo and T. W. Kee, Encapsulation of curcumin in cationic micelles suppresses alkaline hydrolysis,(2008) 5672–5675; DOI: 10.1021/la800780w.
- 6. T. H. Kim, H. H. Jiang, Y. S. Youn, C. W. Park, K. K. Tak, S. Lee, H. Kim and S. Y. Jon, Preparation and characterization of water-soluble albumin bound curcumin nanoparticles with improved antitumor activity,(2011) 285–591; DOI: 10.1016/j.ijpharm.2010.10.041.
- 7. Y. B. Pawar, H. Purohit, G. Valicherla, B. Munjal, S. V. Lale, S. Patel and A. K. Bansal, Novel lipid based oral formulation of curcumin: development and optimization by design of experiments approach,(2012) 617–623; DOI: 10.1016/j.ijpharm.2012.07.031.
- 8. J. Cui, B. Yu, Y. Zhao, W. Zhu, H. Li and H. Lou, Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems,(2009) 148–155; DOI: 10.1016/j.ijpharm.2008.12.009.
- 9. C. G. Chen, T. D. Johnston, H. Jeon, R. Gedaly, P. P. McHugh, T. G. Burke and D. Ranjan, An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B cells,(2009) 133–139; DOI: 10.1016/j.ijpharm.2008.09.009.
- 10. K. Maiti, K. Mukherjee, A. Gantait, B. Saha and P. K. Mukherjee, Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats,(2007) 155–163; DOI: 10.1016/j.ijpharm.
- 11. N. K. Gupta and V. K. Dixit, Bioavailability enhancement of curcumin by complexation with phosphatidylcholine,(2011) 1987–1995; DOI: 10.1002/jps.22393.
- 12. J. Zhang, Q. Tang, X. Xu and N. Li, Development and evaluation of a novel phytosome-loaded chitosan microsphere system for curcumin delivery,(2013) 168–174; DOI: 10.1016/j.ijpharm.2013.03.021.
- 13. P. Shivanand and P. Kinjal, Phytosomes: Technical revolution in phytomedicine,(2010) 627–631.
- 14. J. Patel, R. Patel, K. Khambholja and N. Patel, An overview of phytosomes as an advanced herbal drug delivery system,(2009) 363–371.
- 15. A. Semalty, M. Semalty, B. S. Rawat, D. Singh and M. S. Rawat, Pharmacosomes: the lipid-based new drug delivery system,(2009) 599–612; DOI: 10.1517/17425240902967607.
- 16
- 17. H. I. Benza and W. L. Munyendo, A review of progress and challenges in soft gelatin capsules formulations for oral administration,(2011) 20–24.
- 18. R. P. Gullapalli, Soft gelatin capsules (softgels),(2010) 4109–4121; DOI: 10.1002/jps.22151.
- 19. W. J. Jones, Softgels: consumer perceptions and market impact relative to other oral dosage forms,.(2000) 213–221.
- 20. L. L. Schramm,, Wiley, Weinheim 2005.
- 21. M. Brewster, R. Vandecruys, J. Peeters, P. Neeskens and G. Verreck, Comparative interaction of 2-hydroxypropyl cyclodextrin and sulfobutylether-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions,(2008) 94–103; DOI: 10.1016/j.ejps.2008.02.007.
- 22. M. S. Freag, Y. S. Elnaggar and O. Y. Abdallah, Lyophilized phytosomal nanocarriers as platforms for enhanced diosmin delivery: optimization and ex vivo permeation,(2013) 2385–2397; DOI: 10.2147/IJN.S45231.
- 23. F. Zhang, G. Y. Koh, D. P. Jeansonne, J. Hollingsworth, P. S. Russo, G. Vicente, R. W. Stout and Z. Liu, A novel solubility-enhanced curcumin formulation showing stability and maintenance of anticancer activity,(2011) 2778–89; DOI: 10.1002/jps.22512.
- 24in(Ed. D. Krezhova), InTech 2011, pp. 483–450.
- 25. Z. Hou, Y. Li, Y. Huang, C. Zhou, J. Lin, Y. Wang, F. Cui, S. Zhou, M. Jia, S. Ye and Q. Zhang, Phytosomes loaded with mitomycin C-soybean phosphatidylcholine complex developed for drug delivery,(2013) 90–101; DOI: 10.1021/mp300489p.
- 26. M. A. Elsheikh, Y. S. Elnaggar, E. Y. Gohar and O. Y. Abdallah, Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal,(2012) 3787–3802; DOI: 10.2147/IJN.S33186.
- 27. X. Ren, X. Mao, L. Si, L. Cao and H. Xiong, Pharmaceutical excipients inhibit cytochrome P450 activity in cell free systems and after systemic administration,(2008) 279–288; DOI: 10.1016/j.ejpb.2008.03.019.
- 28. X. Ren, X. Mao, L. Si, L. Cao and J. Qiu, Nonionic surfactants are strong inhibitors of cytochrome P450 3A biotransformation activity in vitro and in vivo,(2009) 401–411; DOI: 10.1016/j.ejps.2008.11.002.
- 29. B. Wahlang, Y. B. Pawar and A. K. Bansal, Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model,(2011) 275–282; DOI: 10.1016/j.ejpb.2010.12.006.
- 30. S. A. Saraf, Applications of novel drug delivery system for herbal formulations,(2010) 680–689; DOI: 10.1016/j.fitote.2010.05.001.
Language: English
Page range: 285 - 297
Accepted on: Jun 25, 2015
Published on: Sep 30, 2015
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2015 Ahmed N. Allam, Ibrahim A. Komeil, Ossama Y. Abdallah, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.